# the Effect of Danhong Injection on Microcirculation in the Treatment of Patients With STEMI After the PTCA Surgery.

Study · id `cardio:ct-nct02158559` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02158559](<https://clinicaltrials.gov/study/NCT02158559>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02158559

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 180 participants.

## Technical summary

Registry record NCT02158559. Randomized; double masking; primary purpose treatment. Start 2014-03 (registry gives no type); primary completion 2015-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 180 participants (planned count; ClinicalTrials.gov record NCT02158559, source copy `cardio:ctgov-nct02158559-2014-06-09`, retrieved 2026-10-26)
- Start date: 2014-03 (registry gives no type) (ClinicalTrials.gov record NCT02158559, source copy `cardio:ctgov-nct02158559-2014-06-09`, retrieved 2026-10-26)
- Primary completion: 2015-12 (anticipated) (ClinicalTrials.gov record NCT02158559, source copy `cardio:ctgov-nct02158559-2014-06-09`, retrieved 2026-10-26)
- Completion: Not reported
- Countries: Not reported
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02158559-2014-06-09`, retrieved 2026-10-26)

## The registry's words

- Brief title: the Effect of Danhong Injection on Microcirculation in the Treatment of Patients With STEMI After the PTCA Surgery.
- Acronym: Danhong
- Condition: Myocardial Infarction
- Intervention (Drug): Danhong Injection
- Intervention (Drug): Normal Saline
- Lead sponsor: Beijing Bozhiyin T&S Co., Ltd.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry lists this organization as the lead sponsor: Beijing Bozhiyin T&S Co., Ltd. (`cardio:org-beijing-bozhiyin-t-s-co-ltd`)

## Provenance

Content hash: 00ade1bd9730a794cb11ae1e9293732b3487bb20f90f73b44454f475736b8496
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
